Difference between revisions of "WSI21-73-Case-3"

From MGH Learn Pathology
Line 53: Line 53:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmlncV9LZEt3blJtWF8yelhaamhhUmE5c2l4amc4SEp2YzNxcUFtZ3h6a2VsRnliTXVPaVkxNDRqa3VOWkQtbXdockhfUEZ6V3RScHprWS1CWEVqaHl4VnFId3c9PQ
 
|subject=Z0FBQUFBQmlncV9LZEt3blJtWF8yelhaamhhUmE5c2l4amc4SEp2YzNxcUFtZ3h6a2VsRnliTXVPaVkxNDRqa3VOWkQtbXdockhfUEZ6V3RScHprWS1CWEVqaHl4VnFId3c9PQ
 +
|reasonCode=Myogenin (MYF-4)
 
|view=show
 
|view=show
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}

Revision as of 13:02, May 25, 2022

WSI21-73-Case-3
33M. History of alveolar rhabdomyosarcoma. Now with pancreatic body mass.
Metastatic alveolar rhabdomyosarcoma
December 31, 1969 7:00:00 PM